Processa Pharmaceuticals PCSA Q4 2025 Disappoints EPS 257 Below 153 Views Oculis OCS Q1 2026 Earnings Miss EPS 049 vs 042 Expected New York Fed Study Reveals Surging Gas Prices Hit LowerIncome Households Hardest Nissan Explores Building Cars for Chinese Rivals at Sunderland Plant Tracking the Economic Effects of Tariffs What Recent Data Suggests Gossamer Bio Shares Slide as Q1 Loss Exceeds Estimates Despite Revenue Surprise Vietnam Dairy Giant Expands US Footprint Following Key Patent Approval HealthEquity HQY Up 194 Is There More Room to Run 20260519 Nexentis Technologies NXTS Gains 136 as Stock Tests Key Resistance Near 470 Franklin Universal Trust FT Edges Higher Approaching Key Resistance Zone Takeda Pharmaceutical TAK Faces Resistance at 1673 Slips 2 Amid Sector Weakness IAF Stock Holds Near Key Resistance Amid Minor Pullback